Sign In
Buy TCOM
$47.94
-0.530 (-1.09%)
At Close: Jun 03, 2026
Trip.com (TCOM) Reports Q2 Loss, Tops Revenue Estimates
09:04pm, Wednesday, 21'st Sep 2022
Trip.com (TCOM) delivered earnings and revenue surprises of -225% and 10.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Previews: Darden Restaurants, KB Home, Lennar, Trip.com
09:43am, Tuesday, 20'th Sep 2022
The three major U.S. equity indexes closed higher Monday. The Dow Jones industrials ended the day up 0.6%, the S&P 500 closed up 0.69% and the Nasdaq added 0.76%.
Trip.com: Too Early To Turn Bullish
06:28am, Thursday, 15'th Sep 2022
Recent tourism numbers for the September 10-12 Mid-Autumn holiday in China were poor as compared to prior years' Mid-Autumn Festivals and other major Chinese holidays this year. Trip.com's Q2 2022 fin
Trip.com Group Limited to Report Second Quarter and First Half of 2022 Financial Results on September 21, 2022 U.S. Time
06:00am, Tuesday, 06'th Sep 2022
SHANGHAI , Sept. 6, 2022 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged
Company News for Jun 29, 2022
01:47pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Companies in The News Are: JEF,TCOM,SNX,EPAC
Amazon To $140? Here's The Biggest Price Target Changes For Wednesday
12:06pm, Wednesday, 29'th Jun 2022 Benzinga
Barclays cut NIKE, Inc. (NYSE: NKE) price target from $140 to $125. Nike shares fell 0.6% to $102.17 in pre-market trading.
JP Morgan lowered Bath & Body Works, Inc. (NYSE: BBWI) price target from
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
08:25am, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Why Trip.com Stock Is Soaring Today
05:15pm, Tuesday, 28'th Jun 2022 The Motley Fool
Strong results in the first quarter led the stock higher.
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
04:17pm, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.
Kezar Life Sciences, Inc.
Why Trip.com Stock Is Soaring Today
01:15pm, Tuesday, 28'th Jun 2022
Strong results in the first quarter led the stock higher.
Oaktree's Howard Marks is finding bargains. 'I am starting to behave aggressively,' he says
12:29pm, Tuesday, 28'th Jun 2022 MarketWatch
Oaktree Capital's founder Howard Marks says now's the time for "bargain" hunting follow the market's selloff.
Here's What's Helping Stocks Take Flight on Tuesday
12:27pm, Tuesday, 28'th Jun 2022 The Motley Fool
Good news on the economic front could help more than just one niche of the market.
Travel Stocks TOUR, TCOM Rise as China Loosens Quarantine Requirements
12:13pm, Tuesday, 28'th Jun 2022
As China eases up on its strict “zero Covid” policy, some travel stocks are heading north with same-day double-digit gains. The post Travel Stocks TOUR, TCOM Rise as China Loosens Quarantine Requi
Best Stocks To Buy Today? 3 Travel Stocks in Focus
12:00pm, Tuesday, 28'th Jun 2022
Check out these travel stocks as China loosens its lockdown restrictions.
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
11:00am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomi
